This will essentially mean faster registration process and project approvals for the industry. Surinder Singh, the Drug Controller General of India (DCGI) announced this at the opening session of the ‘InformExIndia 2009’, a three-day exhibition and network event for fine and specialty chemicals and pharmaceutical industries. The event began today in Ahmedabad.

Singh also informed that 62 Drug Inspectors’ posts will be added in the state to facilitate speedy clearance of applications. He added, “The government is working for implementing best regulatory mechanisms in medical, bio-medical and medical devices industry as well as for ensuring patients’ safety and safe clinical research practices.” Measures like maintenance of a registry of Clinical Research Organisations (CROs), listing of data related to research designs, targets, sponsors’ details and mandatory registration of CROs are also in the pipeline to bring in more transparency in the field, he said.

Singh said various “Pharmaco Vigilance Centres” will be established in select medical colleges throughout the country, in consultation with the Medical Council of India, which will oversee various aspects of safety and adherence to guidelines.

Meanwhile, a panel discussion on the effect of global economic meltdown on pharmaceutical industry will be held tomorrow at the event.